Frequently Asked Questions

No — and any general source that gives you a specific ratio without knowing your exact product, its concentration, and its intended use is giving you a guess dressed up as an answer. Reconstitution volumes are calculated by a pharmacist or prescriber based on the specific vial in front of them. This page explains the science so those instructions make sense; it isn't a substitute for them.

No. Both are sterile, but bacteriostatic water contains a small amount of benzyl alcohol as a preservative, which allows a multi-dose vial to be used safely over a longer period. Plain sterile water has no preservative and is generally intended for immediate or single use. Which one is appropriate depends on the specific product and is a decision made by whoever dispenses it.

Because stability after reconstitution depends on that specific peptide's chemical structure, concentration, and the diluent used. Some combinations remain stable for a couple of weeks refrigerated; others considerably less. There's no universal number — it's specific to the product.

Not necessarily, and it can backfire. Freeze-thaw cycles introduce their own mechanical stress on protein structure. Whether freezing is appropriate for a reconstituted (as opposed to still-lyophilized) product depends on the specific peptide — follow the storage instructions provided with that product rather than a general assumption either way.

Cloudiness or visible particulate after reconstitution is typically a sign that the peptide hasn't fully dissolved, has begun to aggregate, or that contamination has occurred. A clear appearance doesn't guarantee full potency, but a cloudy one is a reliable sign something has gone wrong.

Generally no. Peptides are proteins, and vigorous agitation can physically damage their folded structure, particularly at the air-liquid interface where bubbles form. A gentle swirl or slow rolling motion is the generally recommended alternative.

Photodegradation is cumulative and can begin quickly for light-sensitive compounds. Minimizing light exposure during preparation, and storing vials in an opaque container afterward, is a low-effort way to preserve stability over the vial's full usable life.

No. Diluent choice depends on a given peptide's solubility profile and pH stability — some are formulated with bacteriostatic water, others with sterile water, and others with an acidic diluent like dilute acetic acid. This is a formulation decision made per product, not a general default.

"Research use only" (RUO) is a regulatory labeling category indicating a compound has not been evaluated by the FDA for human administration, and is not required to meet the same manufacturing, purity, or stability-testing standards as a pharmaceutical product. That has direct implications for storage: without validated stability data, there's often no reliable, tested answer for how long an RUO product remains stable once reconstituted. A pharmaceutical-grade product dispensed by a licensed pharmacy comes with pharmacy-verified handling and storage guidance; an RUO product generally does not.

Purity, correct amino acid sequence, and endotoxin levels all affect how a peptide behaves in solution and how it degrades over time. Third-party testing (verifying identity, purity, and sterility) is what makes any general handling guidance actually apply — a compound of unknown purity introduces variables no amount of correct handling technique can fix.

Often, yes — compounding pharmacies formulate products to a prescriber's specifications, which can include concentration and diluent choice. That's precisely why the reconstitution details for a compounded product should come from the pharmacy that made it, not a generic online guide.

Stop and don't use it. Contact the dispensing pharmacy or your prescribing provider, describe what you're seeing, and follow their guidance — this isn't something to troubleshoot on your own or compare against general online descriptions.

Multi-dose vials designed for repeated puncture over time use a self-sealing rubber stopper that reseals after each needle withdrawal, helping maintain sterility across multiple uses. Single-use containers may be designed differently since they aren't intended to be re-entered.

Lyophilized peptides are generally more temperature-tolerant during short shipping windows than reconstituted ones, since there's no water present to drive degradation. That said, manufacturers still specify handling conditions for transit, and prolonged heat exposure can still affect a dry product — which is one reason sourcing from a supplier with verified cold-chain practices matters.

The only genuinely universal rules are the handling principles on our handling page: work sterile, add diluent gently, never shake, keep it cold and dark, track your dates, and inspect before use. Anything more specific — volumes, ratios, exact shelf life — depends on the individual peptide and should come from whoever formulated or dispensed it.

Yes — concentration can influence aggregation risk and stability. A more concentrated solution isn't automatically more or less stable across the board; it depends on the specific peptide's behavior at that concentration, which is exactly why a pharmacist calculates concentration deliberately rather than a patient adjusting it themselves.

An expiration date, set by the original manufacturer, generally applies to the unopened, lyophilized product under specified storage conditions. A beyond-use date is assigned at the point of compounding or reconstitution and reflects a shorter, product-specific window for the now-altered (usually liquid) formulation — the two dates measure different things and the beyond-use date is almost always the sooner one.